Exact Mass: 604.4104
Exact Mass Matches: 604.4104
Found 500 metabolites which its exact mass value is equals to given mass value 604.4104,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
SAPONIN K3
Hederagenin 3-O-arabinoside is a triterpenoid saponin that is hederagenin attached to an alpha-L-arabinopyranosyl residue at position 3 via a glycosidic linkage. It has a role as a plant metabolite. It is a triterpenoid saponin, a monosaccharide derivative, a pentacyclic triterpenoid, a hydroxy monocarboxylic acid and an alpha-L-arabinopyranoside. It is functionally related to a hederagenin. It derives from a hydride of an oleanane. Cauloside A is a natural product found in Lonicera japonica, Hedera caucasigena, and other organisms with data available. See also: Caulophyllum robustum Root (part of). A triterpenoid saponin that is hederagenin attached to an alpha-L-arabinopyranosyl residue at position 3 via a glycosidic linkage. D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors D004791 - Enzyme Inhibitors Cauloside A (Leontoside A) is a saponin isolated from Dipsacus asper roots. Cauloside A has potent antifungal activity[1][2]. Cauloside A (Leontoside A) is a saponin isolated from Dipsacus asper roots. Cauloside A has potent antifungal activity[1][2].
3-Epipapyriferic acid
3-Epipapyriferic acid is a constituent of silver birch (Betula pendula) bark resin, used in manufacture of sweet birch oil. Constituent of silver birch (Betula pendula) bark resin, used in manuf. of sweet birch oil
Ginsenoside Rh3
Ginsenoside Rh3 is found in tea. Ginsenoside Rh3 is isolated from ginseng. Isolated from ginseng. Ginsenoside Rh3 is found in tea.
Cycloartanyl ferulate
Cycloartanyl ferulate is found in cereals and cereal products. Cycloartanyl ferulate is a constituent of rice bran oil Constituent of rice bran oil. Cycloartanyl ferulate is found in cereals and cereal products and fats and oils.
Hebevinoside IV
Toxic constituent of the toxic mushrrom Hebeloma vinosophyllum. Hebevinoside IV is found in mushrooms. Hebevinoside IV is found in mushrooms. Toxic constituent of the toxic mushrrom Hebeloma vinosophyllu
PA(15:0/14:1(9Z))
PA(15:0/14:1(9Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(15:0/14:1(9Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
Polyoxyethylene sorbitan monooleate
PA(10:0/18:1(12Z)-O(9S,10R))
PA(10:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:1(12Z)-O(9S,10R)/10:0)
PA(18:1(12Z)-O(9S,10R)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-O(9S,10R)/10:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(10:0/18:1(9Z)-O(12,13))
PA(10:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:1(9Z)-O(12,13)/10:0)
PA(18:1(9Z)-O(12,13)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(9Z)-O(12,13)/10:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
DG(13:0/PGJ2/0:0)
DG(13:0/PGJ2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/PGJ2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGJ2/13:0/0:0)
DG(PGJ2/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGJ2/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(13:0/0:0/PGJ2)
DG(13:0/0:0/PGJ2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGJ2/0:0/13:0)
DG(PGJ2/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/PGJ2/0:0)
DG(a-13:0/PGJ2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/PGJ2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGJ2/a-13:0/0:0)
DG(PGJ2/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGJ2/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/0:0/PGJ2)
DG(a-13:0/0:0/PGJ2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGJ2/0:0/a-13:0)
DG(PGJ2/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/PGJ2/0:0)
DG(i-13:0/PGJ2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/PGJ2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGJ2/i-13:0/0:0)
DG(PGJ2/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGJ2/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/0:0/PGJ2)
DG(i-13:0/0:0/PGJ2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGJ2/0:0/i-13:0)
DG(PGJ2/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
ZiyuglycosideII
ziyuglycoside II is a natural product found in Sanguisorba officinalis with data available. Ziyuglycoside II is a triterpenoid saponin compound extracted from Sanguisorba officinalis L.. Ziyuglycoside II induces reactive oxygen species (ROS) production and apoptosis. Anti-inflammation and anti-cancer effect[1]. Ziyuglycoside II is a triterpenoid saponin compound extracted from Sanguisorba officinalis L.. Ziyuglycoside II induces reactive oxygen species (ROS) production and apoptosis. Anti-inflammation and anti-cancer effect[1].
Ginsenoside Rh3
Ginsenoside Rh3 is a triterpenoid saponin. Ginsenoside Rh3 is a natural product found in Panax ginseng and Panax notoginseng with data available. Annotation level-1
Ginsenoside RK2
Ginsenoside Rk2 is a natural product found in Panax ginseng and Panax notoginseng with data available.
(3S,4R,5S,6S,3S,4R,5S,6S)-5,6,5,6-tetrahydro-beta,beta-carotene-3,4,3,4-tetrol
1alpha-hydroxycycloartenoid mollic acid 3beta-D-xyloside|mollic acid xyloside
3beta,24-dihydroxyurs-12-en-28-oic acid-24-O-beta-D-xylopyranoside
21-Angeloyl-12-Oleanene-3,15,16,21,22,24,28-heptol
3??-[(??-L-Arabinopyranosyl)oxy]-19??-hydroxyurs-12-en-28-oic acid
Cammeliagenin-A-16-O-cinnamat, 3beta,16alpha,22alpha,28-Tetrahydroxy-Delta12-oleanen-16-O-cinnamat
(5alpha,7alpha,13alpha17alpha,20S,23R,24R)-21,25-epoxy-23,24-dihydroxy-4,4,8-trimethyl-3-oxocholesta-1,14-dien-7-yl benzeneacetic acid ester|turrapubesol C
(3R,5aR,5bR,6R,7S,9S,11aS,12R,13bS)-12-(acetyloxy)icosahydro-7,9-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-1H-cyclopenta[a]chrysen-6-yl benzoate|11alpha-(acetyloxy)-7beta-(benzoyloxy)-21alphaH-24-norhopa-4(23),22(29)-diene-3beta,6beta-diol|cavalerol B
27-hydroxyursolic acid 3-O-alpha-L-arabinopyranoside
Tetra-Ac-(3beta, 5alpha, 6alpha, 15alpha, 24?鈥?-Cholestane-3, 6, 15, 24-tetrol
(3R,5aR,5bR,6R,7S,9S,11aR,12S,13bS)-7-(acetyloxy)icosahydro-9,12-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-1H-cyclopenta[a]chrysen-6-yl benzoate|6beta-(acetyloxy)-7beta-(benzoyloxy)-21alphaH-24-norhopa-4(23),22(29)-diene-3beta,11beta-diol|cavalerol G
24-methylenecycloartane-3beta,6beta,7beta-triol 3-Obeta-D-xylopyranoside
21alpha,24-dihydroxyserrat-14-en-3beta-yl 4-hydroxycinnamate|lycophlegmarinol C
3beta-O-beta-D-glucopyranosyloxy-5alpha-stigmasta-7,9(11),24(28)Z-triene-16beta,29-diol
24-methylenecycloartane-3beta,6beta,16beta-triol 3-Obeta-D-xylopyranoside
24-methylenecycloartane-3beta,7beta,16beta-triol 3-Obeta-D-xylopyranoside
3-methyl-6-{7-ethyl-4-hydroxy- 3,5-dimethyl-6-oxo-7-[5-ethyl-3-methyl-5-(5-ethyl-5-hydroxy-6-methyl-2-tetrahydropyranyl)-2-tetrahydrofuryl]heptyl}salicylic acid, methyl ester
(21alpha-H)-24-norneohopa-4(23),22(29)-diene-3beta,6beta,7beta-triol 7-caffeate
3-O-[alpha-L-arabinopyranosyl]pseudojujubogenin|bacopasaponin H
(5alpha,7alpha,13alpha,17alpha,20S,23R,24R)-21,24-epoxy-23,25-dihydroxy-4,8,8-trimethyl-3-oxocholesta-1,14-dien-7-yl benzeneacetic acid ester|turrapubesol B
(3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16-[(E,2S,3R,4S,8S,9R)-3,9-dihydroxy-4,8,10-trimethyl-5-oxoundec-6-en-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one
(3S,5R,7R,8R,9S,10S,13S,14S,16R,17R)-17-((2R)-7-acetoxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,16-triyl triacetate
Hebevinoside IV
Cycloartanyl ferulate
3-Epipapyriferic acid
3,4,3,4-Tetrahydroxypirardixanthin
4,5-Bis(dicyclohexylphosphino)-9,9-dimethyl-9H-xanthene
2,7-Dihydroxy-3,6,10,11-tetrakis(pentyloxy)triphenylene
Fruticoside C
A steroid saponin that is ergosta-7,24(28)-diene substituted by a hydroxy group at position 2, a methyl group at position 4, a carboxy group at position 21 and a alpha-L-quinovopyranosyloxy group at position 3 (the 2alpha,3beta,4alpha,5alpha stereoisomer). It has been isolated from the roots of Breynia fruticosa.
Cauloside A
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors D004791 - Enzyme Inhibitors Cauloside A (Leontoside A) is a saponin isolated from Dipsacus asper roots. Cauloside A has potent antifungal activity[1][2]. Cauloside A (Leontoside A) is a saponin isolated from Dipsacus asper roots. Cauloside A has potent antifungal activity[1][2].
Isoginsenoside Rh3
2-[2-[3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-(2-hydroxyethoxy)ethoxy]ethyl (E)-octadec-9-enoate
[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate
WURCS=2.0/1,1,0/[hx12xh_3-6_1*OCCOCCCCCCCCC=^ZCCCCCCCCC/6=O_2*OCCO_4*OCCO_5*OCCO]/1
1-Heptadecanoyl-2-lauroyl-sn-glycero-3-phosphate(2-)
(2S,3R,4S,5R)-2-[[(7R,9R,10R,13R,14S,16R,17R)-16-hydroxy-7-methoxy-4,4,9,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol
(3S,5R,7R,8R,9S,10S,13S,14S,16R,17R)-17-((2R)-7-acetoxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,16-triyl triacetate
[(6Z,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14-trienyl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(8R,10R,12S,13R,14S,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2Z)-6-methylhepta-2,5-dien-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol
2,3-dihydroxypropyl [3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]-2-hydroxypropyl] hydrogen phosphate
(5E,7R,8S,9S,11Z,13E,15S,16R)-16-[(E,2S,3R,4S,8S,9R)-3,9-dihydroxy-4,8,10-trimethyl-5-oxoundec-6-en-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one
[3-hydroxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropyl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
[1-Heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] hexadecanoate
[1-Butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] nonadecanoate
[1-Acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] henicosanoate
[1-Hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] heptadecanoate
[1-Octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] pentadecanoate
[1-Nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tetradecanoate
[1-Pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] octadecanoate
[1-Propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] icosanoate
[1-Decanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tridecanoate
[1-[3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] dodecanoate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (Z)-hexacos-15-enoate
(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (Z)-docos-13-enoate
(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (Z)-icos-11-enoate
(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (Z)-tetracos-13-enoate
(1-octanoyloxy-3-phosphonooxypropan-2-yl) (Z)-henicos-11-enoate
(1-phosphonooxy-3-tetradecanoyloxypropan-2-yl) (Z)-pentadec-9-enoate
[3-phosphonooxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] pentadecanoate
(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (Z)-octadec-9-enoate
(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-heptadec-9-enoate
[3-phosphonooxy-2-[(Z)-tridec-9-enoyl]oxypropyl] hexadecanoate
(1-phosphonooxy-3-tridecanoyloxypropan-2-yl) (Z)-hexadec-9-enoate
(1-decanoyloxy-3-phosphonooxypropan-2-yl) (Z)-nonadec-9-enoate
[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-octadec-9-enoate
(5E,7R,8S,9S,11E,13E,15S,16R)-16-[(E,2S,3R,4S,8S,9R)-3,9-dihydroxy-4,8,10-trimethyl-5-oxoundec-6-en-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one
[(2S)-1-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] dodecanoate
[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] (E)-pentadec-9-enoate
[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (E)-hexadec-7-enoate
[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] octadec-17-enoate
[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-octadec-7-enoate
[(2S)-1-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tridecanoate
[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] pentadecanoate
[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-octadec-11-enoate
[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] pentadecanoate
[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] octadec-17-enoate
[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-octadec-7-enoate
[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (E)-heptadec-9-enoate
[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-octadec-4-enoate
[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-octadec-11-enoate
[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-octadec-13-enoate
[(2S)-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-undecanoyloxypropyl] dodecanoate
[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (E)-hexadec-9-enoate
[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-octadec-6-enoate
[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (E)-hexadec-9-enoate
[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-octadec-13-enoate
[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (E)-hexadec-7-enoate
[(2S)-2-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] tridecanoate
[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-octadec-4-enoate
[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]propyl]-trimethylazanium
[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-octadec-9-enoate
[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate
[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (E)-heptadec-9-enoate
[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] (E)-pentadec-9-enoate
[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoate
[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-octadec-6-enoate
[1-carboxy-3-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-propanoyloxypropoxy]propyl]-trimethylazanium
2-[hydroxy-[2-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[3-butanoyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-heptanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[1-carboxy-3-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-pentanoyloxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[3-heptanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium
2-[[2-hexanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-acetyloxy-2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-octanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-octoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-heptanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-butanoyloxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-[(9Z,12Z)-nonadeca-9,12-dienoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-acetyloxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
1-(1Z-octadecenyl)-2-dodecanoyl-glycero-3-phosphate
1-hexadecyl-2-(9Z-tetradecenoyl)-glycero-3-phosphate
1-Heptadecanoyl-2-lauroyl-sn-glycero-3-phosphate(2-)
A 1,2-diacyl-sn-glycerol 3-phosphate(2-) in which the phosphatidyl acyl groups at postions 1 and 2 are specified as heptadecanoyl and lauroyl respectively.
(3s,3as,5ar,5br,6r,7s,7ar,9s,11ar,11br,13ar,13bs)-7,9-dihydroxy-3a,5a,5b,11a-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
4-hydroxy-7,12,16-trimethyl-15-(6-methylhept-5-en-2-yl)-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid
(2s,4ar,4br,6ar,6bs,8as,12as,14ar,14br,16as)-4a,6a,6b,11,11,14b-hexamethyl-2-[(1r,2s,3s)-1,2,3,4-tetrahydroxybutyl]-2h,4h,4bh,5h,6h,7h,8h,9h,10h,12h,12ah,14h,14ah,15h,16h,16ah-piceno[3,4-d][1,3]dioxine-8a-carboxylic acid
3-[(3s,3ar,5ar,6s,7s,9ar,9br)-3-[(2s,5s)-2-hydroxy-6-methyl-5-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}hept-6-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,3ah,5ah,7h,8h,9h-cyclopenta[a]naphthalen-6-yl]propanoic acid
3-{[(1s,3ar,3br,5ar,7r,9ar,9br,11r,11as)-11-(acetyloxy)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid
(3s,4ar,6ar,6bs,8as,11r,12s,12as,14ar,14br)-8a-(hydroxymethyl)-4,4,6a,6b,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
3-(3,4-dihydroxybenzoyl)-4-hydroxy-5-(2-isopropyl-5-methylhex-4-en-1-yl)-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione
(1r,2s)-2-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(1s,2r)-1,2-dihydroxy-2,6,6-trimethylcyclohexyl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-1,3,3-trimethylcyclohexane-1,2-diol
1-[2-(2-{[1,2-dihydroxy-3-(methylamino)decylidene]amino}-3-(4-hydroxyphenyl)-n-methylpropanamido)-4-methylpentanoyl]pyrrolidine-2-carboxylic acid
(1s,3s,4s,6s,7s,8r,11s,12s,15r,16r)-4-hydroxy-7,12,16-trimethyl-15-[(2r)-6-methylhept-5-en-2-yl]-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid
(4as,6as,6br,10s,12ar,12br,14br)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
7-hydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate
2-[2-hydroxy-7-(4-hydroxybenzoyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid
3-{[(1s,3ar,3br,5ar,7r,9ar,9br,11r,11ar)-11-(acetyloxy)-1-[(2s,4e)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid
(3e,5e,7r,8s,9s,11e,13e,15s)-16-[(2s,3r,4s,6e,8s,9r)-3,9-dihydroxy-4,8,10-trimethyl-5-oxoundec-6-en-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one
8a-(hydroxymethyl)-4,4,6a,6b,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate
(2s,3s,4s,5s)-2-{[(1s,2s,3ar,3br,4s,7s,9as,9bs,11ar)-2-hydroxy-4-methoxy-3a,6,6,9b,11a-pentamethyl-1-[(2s)-6-methylhept-5-en-2-yl]-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol
(4as,6as,6br,8ar,9r,10r,12ar,12br,14bs)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(1s,2r,3r,5r,7r,10s,11r,14r,15s)-15-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbutanoate
(1S,4aR,6aR,6aS,6bR,8aR,10S,12aR,14bS)-1-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
{"Ingredient_id": "HBIN003259","Ingredient_name": "(1S,4aR,6aR,6aS,6bR,8aR,10S,12aR,14bS)-1-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid","Alias": "(1S,4aR,6aR,6aS,6bR,8aR,10S,12aR,14bS)-1-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; (1S,4aR,6aR,6aS,6bR,8aR,10S,12aR,14bS)-1-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-[[(2S,3R,4S,5R)-3,4,5-trihydroxy-2-tetrahydropyranyl]oxy]-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid","Ingredient_formula": "C35H56O8","Ingredient_Smile": "NA","Ingredient_weight": "604.81","OB_score": "11.7152079","CAS_id": "108529-23-3","SymMap_id": "SMIT09332","TCMID_id": "NA","TCMSP_id": "MOL007993","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3,23-dihydroxy-12-oleanen-28-oic acid; 3β-form,23-o-alpha-l-arabinopyranoside
{"Ingredient_id": "HBIN007006","Ingredient_name": "3,23-dihydroxy-12-oleanen-28-oic acid; 3\u03b2-form,23-o-alpha-l-arabinopyranoside","Alias": "NA","Ingredient_formula": "C35H56O8","Ingredient_Smile": "NA","Ingredient_weight": "604.81","OB_score": "NA","CAS_id": "83864-75-9","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8410","PubChem_id": "NA","DrugBank_id": "NA"}
3β-[(α-l-arabinopyranosyl)oxy]-19α-hydroxy-olean-12-en-28-oicacid
{"Ingredient_id": "HBIN008165","Ingredient_name": "3\u03b2-[(\u03b1-l-arabinopyranosyl)oxy]-19\u03b1-hydroxy-olean-12-en-28-oicacid","Alias": "NA","Ingredient_formula": "C35H56O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14347","TCMID_id": "1579","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β-[(α-l-arabinopyranosyl)oxy]-19α-hydroxy-urs-12-en-28-oicacid
{"Ingredient_id": "HBIN008168","Ingredient_name": "3\u03b2-[(\u03b1-l-arabinopyranosyl)oxy]-19\u03b1-hydroxy-urs-12-en-28-oicacid","Alias": "NA","Ingredient_formula": "C35H56O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14352","TCMID_id": "1584","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-β-o-α-l-arabinopyranosyl jujubogenin
{"Ingredient_id": "HBIN008280","Ingredient_name": "3-\u03b2-o-\u03b1-l-arabinopyranosyl jujubogenin","Alias": "NA","Ingredient_formula": "C35H56O8","Ingredient_Smile": "CC(=CC1CC(C2C3CCC4C5(CCC(C(C5CCC4(C36CC2(O1)OC6)C)(C)C)OC7C(C(C(CO7)O)O)O)C)(C)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1574","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3beta-p-hydroxybenzoyldehydrotumtlosic acid
{"Ingredient_id": "HBIN008331","Ingredient_name": "3beta-p-hydroxybenzoyldehydrotumtlosic acid","Alias": "NA","Ingredient_formula": "C38H52O6","Ingredient_Smile": "CC(C)C(=C)CCC(C1C(CC2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)OC(=O)C5=CC=C(C=C5)O)C)C)C)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31157","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β-p-hydroxybenzoyldehydrotumulosicacid
{"Ingredient_id": "HBIN008332","Ingredient_name": "3\u03b2-p-hydroxybenzoyldehydrotumulosicacid","Alias": "NA","Ingredient_formula": "C38H52O6","Ingredient_Smile": "CC(C)C(=C)CCC(C1C(CC2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)OC(=O)C5=CC=C(C=C5)O)C)C)C)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15813","TCMID_id": "9822","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-O-alpha-L-Arabinopyranosyl-3 beta,23-dihydroxy-lup-20(29)-en-28-oic acid
{"Ingredient_id": "HBIN009068","Ingredient_name": "3-O-alpha-L-Arabinopyranosyl-3 beta,23-dihydroxy-lup-20(29)-en-28-oic acid","Alias": "3-o-alpha-l-arabinopyranosyl-3 beta,23-dihydroxy-lup-20(29)-en-28-oic acid","Ingredient_formula": "C35H56O8","Ingredient_Smile": "Not Available","Ingredient_weight": "604.91","OB_score": "5.835593072","CAS_id": "NA","SymMap_id": "SMIT01113","TCMID_id": "30625","TCMSP_id": "MOL001958","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
